Investor Relations & Capital Introduction in Oxford

Oxford is home to the University of Oxford and one of Europe's most productive sources of university spinout companies. For founders in life sciences, quantum technology and deep technology, it offers world-class research and dedicated investment capital.

Why Oxford Matters for Capital Raising

Oxford Science Enterprises, established in 2015, invests specifically in companies emerging from the university and has helped build a large spinout ecosystem.

The university's research has produced major commercial outcomes, including the Oxford–AstraZeneca COVID-19 vaccine and a number of quantum computing and biotechnology companies.

Nearby Culham and Harwell host fusion energy and national science facilities, adding further depth.

What Oxford Investors Examine

Scientific foundations, intellectual property and university licensing terms are examined closely.

Investors look for a credible route from research to a commercial product.

Engagement and Access

GCN connects founders with Oxford specialist funds, angel investors and family offices through conference programming and private sessions across the UK.

Sectors where we see consistent Oxford interest include life sciences and vaccines, quantum technology, fusion and clean energy, artificial intelligence and medical devices.

Partner with Global Capital Network

Whether you are raising into Oxford or allocating from it, our team can discuss how our investor relations infrastructure applies to your objectives.